Fenwick & West LLP advised Inipharm on the deal. Inipharm, a biopharmaceutical company focused on discovering and developing therapies for severe liver diseases, announced its $35…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now